Yau-Tuen Chan

Nanomedicines for resistant tumours in the central nervous system: novel materials and mechanisms of action

Central nervous system (CNS) tumours have a dismal prognosis, primarily due to the systemic therapeutic resistance that tumours develop through complex multidimensional networks. Factors related to therapeutic efficacy include: (i) natural physical barriers (e.g., the blood–brain...